Domino Reactions in Drug Design and Discovery

Title:Domino Reactions in Drug Design and Discovery

Volume: 13 Issue: 3

Author(s): Shanta Bhar and Mucheli M.V. Ramana

Affiliation:

Keywords: Domino reactions, multicomponent, synthesis, cyclization, drug design.

Abstract: With reference to challenges in developing varied and exceedingly complex scaffolds expeditiously through atom economy, domino reactions have assumed a significant role in several transformative endeavors towards established pharmaceuticals and new chemical entities across diverse therapeutic classes such as HIV integrase inhibitors, DPP4 [dipeptidyl peptidase IV] inhibitors, GSK- 3 (Glycogen Synthase Kinase 3) inhibitors, neoplastic drugs and microtubule antagonists. The very large chemical space of Domino Reactions can be leveraged for the design strategy of drugs and drug- like candidates with leading examples like Indinavir (Crixivan), Trandolapril (Mavik), Biyouyanagin A, endo pyrrolizidinone diastereomer [GSK] and several others. Domino reactions therefore constitute an integral part of both creative and functional aspects of drug design and discovery, contributing both enhanced efficiency as well as synthetic versatility to pharmaceutical drug design.

Cite this article as:

Bhar Shanta and Ramana M.V. Mucheli, Domino Reactions in Drug Design and Discovery, Current Drug Discovery Technologies 2016; 13 (3) . https://dx.doi.org/10.2174/1570163813666160819105059